- Home
- NRIX vs SA Comparison
NRIX vs SA Comparison
Compare NRIX & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | SA |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | NRIX | SA |
|---|---|---|
| Price | $25.37 | $24.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | $34.50 | ★ $59.06 |
| AVG Volume (30 Days) | ★ 1.9M | 451.1K |
| Earning Date | 10-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.26 | N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | $786.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.82 | ★ N/A |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $11.19 | $21.67 |
| 52 Week High | $28.23 | $40.06 |
Technical Indicators
Market Signals| Indicator | NRIX | SA |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 32.39 |
| Support Level | $24.61 | $24.22 |
| Resistance Level | $28.23 | $28.33 |
| Average True Range (ATR) | 1.21 | 0.96 |
| MACD | 0.39 | -0.13 |
| Stochastic Oscillator | 81.41 | 23.70 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development-stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.